Harmony Biosciences Holdings (HRMY) Profit After Tax (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Harmony Biosciences Holdings | 1.83 Bn | 1.19 Bn | 170.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.48% |
| Dec 31, 2025 | -55.79% |
| Sep 30, 2025 | 27.88% |
| Jun 30, 2025 | -12.70% |
| Mar 31, 2025 | -7.91% |
| Dec 31, 2024 | 7.34% |
| Sep 30, 2024 | 297.66% |
| Jun 30, 2024 | -69.76% |
| Mar 31, 2024 | 44.07% |
| Dec 31, 2023 | -30.82% |
| Sep 30, 2023 | 12.13% |
| Jun 30, 2023 | 16.33% |
| Mar 31, 2023 | -39.22% |
| Dec 31, 2022 | -44.84% |
| Sep 30, 2022 | 273.73% |
| Jun 30, 2022 | 9.52% |
| Mar 31, 2022 | -5.41% |
| Dec 31, 2021 | 336.11% |
| Sep 30, 2021 | -168.14% |
| Jun 30, 2021 | 91.13% |
| Mar 31, 2021 | 3,650.96% |
| Dec 31, 2020 | -110.90% |
| Sep 30, 2020 | 7,170.37% |
| Jun 30, 2020 | 99.93% |
| Mar 31, 2020 | -5.98% |
| Dec 31, 2019 | -14.24% |